|
|
|
eBook/Digital Version available from:
|
Score: 89 |
 |
| Framework for Equitable Allocation of COVID-19 Vaccine |
|
ISBN: 978-0-309-68224-4,
252 pages,
Soft Cover
ISBN-10: 0-309-68224-X |
|
| Copyright: |
2020 |
|
| Edition: |
1st |
|
| Author: |
National Academies of Sciences, Engineering, and Medicine |
|
|
Specialties:
|
Infectious Disease
, Public Health |
|
| Publisher: |
National Academies Press |
|
500 5th Street, NW |
|
Keck 360 |
|
Washington, DC 20001 |
|
UNITED STATES |
|
P: 8006246242
F: 202-334-2793 |
|
http://www.nap.edu |
|
| List Price: |
$65.00 |
|
| Google: |
|
|
|
|
|
|
|
At A Glance
|
Contributors: Health and Medicine Division; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine. To order, please visit the publisher's website
|
|
Reviewer:
|
Margaret Griffin,
BA,MPH,MD
(Retired)
|
|
|
Range
|
Question
|
Score
|
| 1-10 |
Are the author's objectives met? |
8 |
| 1-10 |
Rate the worthiness of those objectives. |
10 |
| 1-5 |
Is this written at an appropriate level? |
5 |
| 1-5 |
Is there significant duplication? (1=significant, 5=insignificant) |
3 |
| 1-5 |
Are there significant omissions? (1=significant, 5=insignificant) |
5 |
| 1-5 |
Rate the authority of the authors. |
5 |
| 1-5 |
Are there sufficient illustrations? |
5 |
| 1-5 |
Rate the pedagogic value of the illustrations. |
3 |
| 1-5 |
Rate the print quality of the illustrations. |
4 |
| 1-5 |
Are there sufficient references? |
5 |
| 1-5 |
Rate the currency of the references. |
4 |
| 1-5 |
Rate the pertinence of the references. |
4 |
| 1-5 |
Rate the helpfulness of the index. |
5 |
| 1-5 |
If important in this specialty, rate the physical appearance of the book |
N/A |
| 1-10 |
Is this a worthwhile contribution to the field? |
10 |
| 1-10 |
If this is a 2nd or later edition, is this new edition needed? |
N/A |
|
|
|
Reviewer:
|
Margaret Griffin,
BA,MPH,MD
(Retired)
|
|
|
Description
|
| The purpose of this consensus study is to recommend race, ethnicity, and health equality in the distribution of COVID-19 vaccines when they are available for vulnerable populations. In the U.S. and worldwide, studies have shown a more deleterious effect by virtue of race, age, health status, occupation, and other socioeconomic conditions. Current evidence has shown how COVID-19 disproportionately affects Black, Hispanic, American Indian, Alaska Native, Native Hawaiian, and Pacific Islander communities. |
|
|
Purpose
|
| Because this study is a consensus report, the description and purpose of the book are the same. The studies elaborated, tabled, and graphed are very relevant to eliminating the COVID-19 pandemic as soon as possible. The recommendations of this multidisciplinary panel are very much needed and very helpful in planning the most advantageous distribution of COVID-19 vaccines when available. This report summarizes and lists scientific data that backs the committee's recommendations and meets the objectives set forth by the panel. |
|
|
Audience
|
| This book is written for professionals addressing the COVID-19 crisis from a national governmental strategy, designated government agencies addressing the COVID-19 crisis, and academic institutions with medical and hospital staff taking care of patients with COVID-19 patients on a daily basis. The study meets the needs of all of these organizations. The task force making these recommendations includes very valuable experts in their designated fields based on the diversity of their expertise addressing the equity issues discussed. |
|
|
Features
|
| Following the summary statement of the report, the report outlines by chapter: 1) lessons previously learned from past vaccine allocations; 2) a framework for vaccine allocation; 3) coordination and administration of an effective vaccine on an equitable basis; 4) risk communication and community engagement; 5) vaccine acceptance; and 6) ensuring equity of the COVID-19 vaccine globally. Simple tables and diagrams in individual sections are very helpful illustrating the text described. |
|
|
Assessment
|
| This book is very useful in outlining the various areas that need to be addressed to educate the public about COVID-19 and plan nationwide programs for distributing the vaccines to everyone eligible and interested in getting vaccinated as the vaccines become available. The book effectively documents the well-researched recommendations for tier priorities from most vulnerable to least vulnerable. |
|
|
|
|
|
|
|
|
